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ABSTRACT
Chemical exchange saturation transfer (CEST) and magnetization transfer (MT) are types
of magnetic resonance imaging (MRI) experiments in which contrast is based on the transfer of
magnetization from selectively saturated solute or macromolecular protons to bulk water protons.
These processes offer insight into the chemical composition of tissue and are quantified by the
asymmetry of the magnetization transfer ratio (MTRasym). This study was to develop a Z-spectral
curve fitting procedure based on the underlying physics of CEST-MRI from which MTRasym
values can be calculated and applied to distinguish healthy tissue from cancer.
Z-spectra were collected from CEST-MR images of a phantom. The data were fit to both
the proposed model which separately fits the upfield and downfield regions of the Z-spectra, and
two polynomial models from literature. A preferred model was identified using the small sample
bias-corrected Akaike’s Information Criterion (AICc). Z-spectra were collected from CEST-MR
images of prostate cancer patients and fit with the same models; the preferred model was
selected using the AICc. CEST-MR images of bladder cancer patients were acquired and the Zspectra were fit with the preferred model identified from the phantom images. MTRasym was
calculated at frequency offsets of 3.5 ppm and 2.0 ppm to determine if these quantities were
capable of distinguishing normal bladder wall (NBW) from bladder cancer.
The proposed fitting model with a 5th order polynomial for the downfield region was the
preferred curve fitting model by the AICc model selection procedure for the phantom while a 6th
order polynomial was preferred for the prostate cancer Z-spectra. MTRasym(2.0 ppm) values
calculated from the bladder cancer Z-spectra did not differ significantly between the NBW and
tumor regions. A statistically significant difference existed between the NBW and tumor regions
for the MTRasym(3.5 ppm) values (p < 0.001).

xi

The proposed model was preferred to the polynomial models from literature based on the
AICc metric. Application of the technique to patient images showed the potential to distinguish
NBW from bladder cancer based on the statistically significant MTRasym(3.5 ppm) values in
these regions.

xii

CHAPTER 1: INTRODUCTION
1.1 MRI PHYSICS REVIEW
1.1.1 NUCLEAR MAGNETIC RESONANCE
Some species of nuclei have an intrinsic magnetic moment, which will be oriented
isotropically in a material under normal conditions. In the presence of a strong external magnetic
field, these magnetic moments will align to either parallel (low energy) or antiparallel (high
energy) states to create a net magnetic moment oriented in the direction of the external magnetic
field (Figure 1.1). The ratio of the number of protons in the low energy state to the number of
protons in the high energy state is determined by
𝑛𝑠𝑝𝑖𝑛 𝑢𝑝
𝑛𝑠𝑝𝑖𝑛 𝑑𝑜𝑤𝑛

= 𝑒−

ℏ𝛾𝐵0
𝑘𝑇

(1.1)

where γ represents the gyromagnetic ratio (42.58 MHz/T for hydrogen nuclei), ħ is the
Dirac constant (1.05 × 10-34 Js), k is the Boltzmann constant (1.38 × 10-23 m2kgs-2K-1), T is the
temperature (37˚C for the human body), and B0 is the strength of the external magnetic field
(Haacke, Brown et al. 1999). The gyromagnetic ratio, γ, is a property of the nucleus. For MR
imaging of the human body, the hydrogen nucleus due to the large abundance of both water and
fat in the human body (Westbrook, Roth et al. 2011).
a)

b)

Figure 1.1: (a) Alignment of proton magnetic moments in the absence of a magnetic field, and
(b) in the presence of a strong external magnetic field. Adapted from Westbrook 2011.
1

Although the net magnetic moment aligns with the external magnetic field, the magnetic
moments of the individual hydrogen nuclei maintain an angle of 54.73˚ from the direction of the
external magnetic field and precess about this field at the resonance or Larmor frequency, ω0,
given by
𝜔0 = 𝛾𝐵0

(1.2)

where γ is the gyromagnetic ratio and B0 is the strength of the external magnetic field (Figure
1.2). For hydrogen nuclei in a 3 T external magnetic field, the Larmor frequency is 127.7 MHz.

B0

Figure 1.2: The precession of an individual magnetic moment about the direction of the external
magnetic field. Adapted from Westbrook 2011.
1.1.2 CHEMICAL SHIFT
Though all nuclei of a single species have a constant gyromagnetic ratio, the resonance
frequency of these nuclei can change based on the electronic environment. Changes in geometry
2

including bond length and bond angle, as well as the electronegativity of elements participating
in a bond, affect the net magnetic field experienced by an individual nucleus. From Equation 1.2,
a change in magnetic field strength changes the resonance frequency of the nucleus. This shift is
often expressed in units of parts per million (ppm or Hz/MHz), calculated as
Δ𝜔 =

𝜔−𝜔𝑟𝑒𝑓
𝜔𝑟𝑒𝑓

(1.3)

where ω is the resonance frequency of the shifted nucleus and ωref is the resonance frequency of
a reference material. Tetramethylsilane (TMS) is commonly chosen as a reference material.
Due to the effect of chemical structure on the resonance frequency of nuclei, NMR
spectroscopy is able to identify the types of bonds in a sample (Figure 1.3).

Figure 1.3: The amount of chemical shift varies depending on molecular structure and the
electronegativity of participating atoms. Figure adapted from the University of Colorado's
organic chemistry NMR theory tutorial (orgchem.colorado.edu).
1.1.3 MAGNETIC SUSCEPTIBILITY
Magnetic susceptibility is a property of a material that describes the relationship between
the magnetization of the material and the strength of an applied external magnetic field, which
3

causes differences in the Larmor frequency of protons in the context of MRI. This change in
Larmor frequency causes signal loss at the interface between materials with different magnetic
susceptibilities, and the magnitude of the resulting artifact (Figure 1.4) can range from
insignificant to severe; the presence of ferromagnetic materials especially causes B0 field
inhomogeneity in surrounding tissues.

Figure 1.4: Magnetic susceptibility artifact due to a metallic substance located on the surface of
the patient's skin. This case is courtesy of Dr. Ayush Goel of Radiopaedia.org.
The B0 field inhomogeneities caused by differences in magnetic susceptibility between
tissues and even in regions within a tissue also have an effect on chemical shift and MR
spectroscopy. The resonance frequency of protons is shifted an amount based on the magnitude
of the B0 field inhomogeneity as described by the Larmor equation (Equation 1.2). The entire
MR spectrum becomes shifted laterally along the frequency axis.
1.2 MAGNETIZATION TRANSFER
The T2 relaxation time of protons associated with immobile macromolecules is too short
for direct imaging with standard 1H MRI (Henkelman, Stanisz et al. 2001). However, these

4

macromolecular protons can be detected indirectly based on the interactions with water protons.
An off-resonance radiofrequency saturation pulse can selectively excite the macromolecular
spins; the magnetization will subsequently be transferred to water protons (Figure 1.5) through a
combination of spin-spin interactions and direct chemical exchange of protons. This
magnetization transfer (MT) process is described using a two pool model, with one pool
representing the water protons (bulk water pool or free pool) and the other representing the
macromolecular protons (bound pool), each with their own relaxation rates and an exchange rate
between the two pools (Figure 1.6). Though the goal of magnetization transfer MRI (MT-MRI)
is to detect changes in the bulk water pool due to MT from the bound pool, some direct
saturation of the water pool (direct water saturation, DWS) always occurs when the saturation
pre-pulse is applied.

Figure 1.5: An off-resonance RF saturation pulse applied to the bound pool reduces the signal
detected from the water pool following magnetization transfer. Adapted from Henkelman 2001.

5

Figure 1.6: The larger pool (A) representing the water pool, and a smaller macromolecular pool
(B). The exchange rate R describes the transfer of magnetization between the two pools. Adapted
from Henkelman 2001.
The magnetizations of the two pools in this model are described by the Bloch equations,
modified to include exchange terms:
𝑑𝑀𝑧𝑎
𝑑𝑡
𝑑𝑀𝑧𝑏
𝑑𝑡

= 𝑅𝑎 (𝑀0𝑎 − 𝑀𝑧𝑎 ) − 𝑅𝑀0𝑏 𝑀𝑧𝑎 + 𝑅𝑀0𝑎 𝑀𝑧𝑏 + 𝜔1 𝑀𝑦𝑎

(1.4)

= 𝑅𝑏 (𝑀0𝑏 − 𝑀𝑧𝑏 ) − 𝑅𝑀0𝑎 𝑀𝑧𝑏 + 𝑅𝑀0𝑏 𝑀𝑧𝑎 + 𝜔1 𝑀𝑦𝑏

(1.5)

𝑑𝑀𝑥𝑎
𝑑𝑡
𝑑𝑀𝑥𝑏
𝑑𝑡
𝑑𝑀𝑦𝑎
𝑑𝑡
𝑑𝑀𝑦𝑏
𝑑𝑡

𝑀𝑎

= − 𝑇 𝑥 − 2𝜋Δ𝑀𝑦𝑎
2𝑎

𝑀𝑏

= − 𝑇 𝑥 − 2𝜋Δ𝑀𝑦𝑏
2𝑏

𝑀𝑎

= − 𝑇 𝑦 + 2𝜋Δ𝑀𝑥𝑎 − 𝜔1 𝑀𝑧𝑎
2𝑎

𝑀𝑏

= − 𝑇 𝑦 + 2𝜋Δ𝑀𝑥𝑏 − 𝜔1 𝑀𝑧𝑏
2𝑏

(1.6)
(1.7)
(1.8)
(1.9)

where Mij represents the ith component (x, y, or z) of the magnetization of the jth pool (a = water
and b = bound), R is the exchange rate, Ra,b is the longitudinal relaxation rates of the water and
bound pools (A and B), M0a,b is the magnetization in the absence of saturation, Δ is the frequency
offset of the RF saturation pulse (in Hz), T2a,b is the transverse relaxation times for the water (a)
and bound (b) pools, and ω1 is the angular frequency of precession caused by the RF saturation
6

pulse (Henkelman, Huang et al. 1993). Assuming steady state, these equations may be solved to
provide a description of the magnetization of the water pool
𝑀𝑧𝑎 =

𝑅𝑏 (
(

𝑅𝑀𝑏
0
)+𝑅𝑟𝑓𝑏 +𝑅𝑏 +𝑅
𝑅𝑎

𝑅𝑀𝑏
𝜔1 2
1
0 )(𝑅 +𝑅
𝑏
𝑟𝑓𝑏 )+(1+(2𝜋Δ) (𝑅 𝑇 )(𝑅𝑏 +𝑅𝑟𝑓𝑏 +𝑅)
𝑅𝑎
𝑎 2𝑎

(1.10)

where Rrfb is a function describing the RF absorption rate of the bound pool. While the solution
of Equations 1.4-1.9 suggests a Lorentzian line shape for both the water and bound pools,
experiments have shown a Gaussian function better fits the bound pool in agar, and a superLorentzian better fits the bound pool in tissue (Morrison and Henkelman 1995).
The imaging procedure for MT-MRI consists of a narrow-band RF saturation pre-pulse
applied immediately prior to the image acquisition sequence (Figure 1.7). Common pulse
sequences used to acquire these images include 2D single-slice fast spin echo or fast gradient
echo techniques and 3D echo planar imaging techniques. In principle, the saturation pre-pulse
can be applied prior to any image acquisition sequence, but in practice, fast imaging techniques
are preferred to minimize the decay of the MT effect (Zaiss and Bachert 2013).

Figure 1.7: MT-MRI is performed by applying a RF saturation pre-pulse (red, left) prior to a
standard imaging pulse sequence (right). Adapted from Zaiss 2013.
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The effect of MT has been traditionally quantified by the magnetization transfer ratio, or
MTR, which is calculated as:
𝑀𝑇𝑅 = 1 −

𝑆𝑠𝑎𝑡
𝑆0

(1.11)

where Ssat is the signal intensity with the saturation pre-pulse and S0 is the signal intensity in the
absence of saturation.
Graphically, the effect of MT may be depicted by plotting signal intensity as a function of
the frequency offset of the applied saturation pre-pulse (Figure 1.8). This often is called the Zspectrum, or MT-spectrum (Bryant 1996). The plotted signal intensity is often normalized by the
signal intensity in the absence of saturation, so the Z-spectrum may alternatively be thought of as
the plot of 1-MTR versus the frequency offset of the applied saturation pre-pulse. However, for
many MT-MRI experiments, the entire Z-spectrum need not be collected; a single image with the
saturation pre-pulse applied at a sufficiently large frequency offset is often adequate for the
purpose of MTR calculations (Kumar, Jagannathan et al. 2008).

Figure 1.8: A hypothetical Z-spectrum for conventional MT from immobile macromolecules has
a large width, with noticeable MT effects at saturation frequency offsets of 100 kHz. Adapted
from Zhou 2006.
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1.3 APPLICATIONS OF MAGNETIZATION TRANSFER MRI
MT-MRI has previously been applied to enhance contrast in MR angiography (Parker,
Buswell et al. 1995) and brain imaging for multiple sclerosis (Mehta, Pike et al. 1995, Tozer,
Ramani et al. 2003). Recently, quantitative MT-MRI has been utilized to detect the
macromolecular protons in the prostate to distinguish cancer from healthy tissue (Arima,
Hayashi et al. 1999, Kumar, Jagannathan et al. 2008, Kumar, Jagannathan et al. 2012), as
prostate cancer tissues exhibit greater MT effects than healthy peripheral zone tissues based on
the greater amount of relatively stationary structural tissue proteins and lipids (Riches 2009).
MTR has recently been studied as a potential biomarker for bowel fibrosis (Pazahr, Blume et al.
2013, Martens, Lambregts et al. 2014). As of May 2015, there have been over 1700 publications
on MT-MRI and over 400 publications on quantitative MT-MRI indexed in PubMed since 1988.
1.4 CHEMICAL EXCHANGE SATURATION TRANSFER
Chemical exchange saturation transfer (CEST) is a type of magnetization transfer where
the decrease in water signal is due to the exchange of protons between solute molecules and
water. Like MT from immobile macromolecules, CEST is most simply described using a two
pool model with one pool representing the solute protons and the other pool representing the
water protons. Unlike the protons associated with immobile macromolecules which have a broad
RF absorption line shape that is approximately centered about water resonance, the solute
protons have an RF absorption line shape that is narrow and asymmetric with respect to water
resonance (Figure 1.9). The chemical shifts of some physiologically relevant types of solute
protons are shown in Figure 1.10. (Zhou and van Zijl 2006)
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Figure 1.9: The RF absorption spectra of water and a NH solute pool (left) have a much narrower
bandwidth than that of the broad macromolecular pool describing traditional magnetization
transfer. Much like traditional MT, saturation is transferred to the water pool, reducing the
amount of detectable water signal (right). Adapted from Ziv 2013.

Figure 1.10: The chemical shifts of common solute protons for CEST-MRI in vivo. Adapted
from Liu 2013.
Similar to magnetization transfer from immobile macromolecules, the magnetization of
the water and solute pools may be described by modified versions of the Bloch equations which
include exchange terms:
𝑑𝑀𝑥𝑠

= −Δ𝜔𝑠 𝑀𝑦𝑠 − 𝑅2𝑠 𝑀𝑥𝑠 − 𝑘𝑠𝑤 𝑀𝑥𝑠 + 𝑘𝑤𝑠 𝑀𝑥𝑤

(1.12)

= Δ𝜔𝑠 𝑀𝑥𝑠 + 𝜔1 𝑀𝑧𝑠 − 𝑅2𝑠 𝑀𝑦𝑠 − 𝑘𝑠𝑤 𝑀𝑦𝑠 + 𝑘𝑤𝑠 𝑀𝑦𝑤

(1.13)

= −𝜔1 𝑀𝑦𝑠 − 𝑅1𝑠 (𝑀𝑧𝑠 − 𝑀0𝑠 ) − 𝑘𝑠𝑤 𝑀𝑧𝑠 + 𝑘𝑤𝑠 𝑀𝑧𝑤

(1.14)

𝑑𝑡
𝑑𝑀𝑦𝑠
𝑑𝑡
𝑑𝑀𝑧𝑠
𝑑𝑡

𝑑𝑀𝑥𝑤

= −Δ𝜔𝑤 𝑀𝑦𝑤 − 𝑅2𝑤 𝑀𝑥𝑤 + 𝑘𝑠𝑤 𝑀𝑥𝑠 − 𝑘𝑤𝑠 𝑀𝑥𝑤

(1.15)

= Δ𝜔𝑤 𝑀𝑥𝑤 + 𝜔1 𝑀𝑧𝑤 − 𝑅2𝑤 𝑀𝑦𝑤 + 𝑘𝑠𝑤 𝑀𝑦𝑠 − 𝑘𝑤𝑠 𝑀𝑦𝑤

(1.16)

𝑑𝑡
𝑑𝑀𝑦𝑤
𝑑𝑡

10

𝑑𝑀𝑧𝑤
𝑑𝑡

= −𝜔1 𝑀𝑦𝑤 − 𝑅1𝑤 (𝑀𝑧𝑤 − 𝑀0𝑤 ) + 𝑘𝑠𝑤 𝑀𝑧𝑠 − 𝑘𝑤𝑠 𝑀𝑧𝑤

(1.17)

where Mij represent the ith component (x, y, and z) of the magnetization of the jth pool (s = solute,
w = water); ksw and kws represent the first order exchange rates from the solute pool to the water
pool and the water pool to the solute pool, respectively; ω1 = γB1 where γ is the gyromagnetic
ratio and B1 is the magnitude of the applied RF saturation pulse; Δω is defined as ω – ω0 where ω
is the location of the applied RF saturation field and ω0 = γB0 for external magnetic field strength
B0; and R2 and R1 are the transverse and longitudinal relaxation rates, respectively, of the water
pool (w) and solute pool (s). These equations apply when the RF saturation pulse is applied
along the x-direction. (Zhou, Wilson et al. 2004)
The imaging procedure for CEST-MRI is similar to the procedure for MT-MRI; an RF
saturation pre-pulse is applied immediately prior to image acquisition. As with MT-MRI, fast
imaging techniques such as echo planar imaging (EPI), fast spin echo, and fast gradient echo
acquisitions are commonly used to minimize the decay of the transferred magnetization.
Typically many images are acquired, covering a range of saturation frequency offsets. (Zaiss and
Bachert 2013)
As with traditional MT, the CEST effect is displayed graphically as the Z-spectrum. The
solute pools have narrow RF absorption spectra compared to the immobile macromolecules,
which provide traditional MT, and the location of these absorption spectra near the water
resonance introduces asymmetry to the Z-spectra (Figure 1.11a and b).
The CEST effect is described quantitatively as the asymmetry of the MTR with respect to
water resonance (Figure 1.11c) at a particular offset frequency, MTRasym(ω), which is defined as:
𝑀𝑇𝑅𝑎𝑠𝑦𝑚 (𝜔) =

𝑆𝑠𝑎𝑡 (−𝜔)−𝑆𝑠𝑎𝑡 (+𝜔)
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𝑆0

(1.18)

where Ssat(-ω) is the signal intensity with the saturation pulse applied at a frequency offset of –ω,
Ssat(+ω) is the signal intensity with the saturation pulse applied at a frequency offset of +ω, and
S0 is the signal intensity in the absence of saturation (Zaiss and Bachert 2013). Another
commonly used method of quantifying the CEST effect is the CEST ratio or CESTR, which is
defined as:
𝐶𝐸𝑆𝑇𝑅(𝜔) =

𝑆𝑠𝑎𝑡 (−𝜔)−𝑆𝑠𝑎𝑡 (+𝜔)
𝑆𝑠𝑎𝑡 (−𝜔)

(1.19)

The analysis of asymmetry is based on the assumption that the only two factors
contributing to the Z-spectrum are DWS and the CEST effect; by calculating asymmetry under
these conditions, the DWS contribution to the MTR is removed.

Figure 1.11: (a) The 1H spectrum, showing a peak for the water pool and smaller solute pool,
which disappears after saturation and (b) the resulting Z-spectrum, with an apparent asymmetry
at the location of the solute pool. (c) CEST-MRI is quantitatively analyzed by calculating the
asymmetry of the Z-spectrum. Adapted from Liu 2013.
Alternatively, one study investigated removing the DWS contribution through Fourier
transform analysis in a technique called time domain removal of irrelevant magnetization
(TRIM) rather than calculating MTR asymmetry (Yadav, Chan et al. 2013). In this technique, the
12

MTR as a function of saturation frequency offset is Fourier transformed into the time domain,
where the signal is fit to a combination of three Lorentzian functions. The portion corresponding
to DWS is removed from the time domain signal and transformed back into the frequency
domain, yielding a measure of MTR with the contribution from DWS removed.
1.5 APPLICATIONS OF CHEMICAL EXCHANGE SATURATION TRANSFER MRI
The unique contrast mechanism provided by CEST-MRI has a number of potential
applications, including distinguishing tumor from healthy tissue (Jia, Abaza et al. 2011),
monitoring change in creatine concentration in skeletal muscle following exercise (Kogan, Haris
et al. 2014), imaging cartilage based on chemical exchange between glycosaminoglycans and
water (Singh, Haris et al. 2012), and monitoring breast cancer response to chemotherapy (Dula,
Arlinghaus et al. 2013). Studies have demonstrated an increased CEST effect in brain tumors,
and have applied CEST-MRI to distinguish peritumoral edema from white matter and to
differentiate orthotopic gliomas from radiation induced necrosis (Kogan, Hariharan et al. 2013).
As of May 2015, there have been 351 publications on CEST-MRI indexed in PubMed.
1.6 EXTERNAL MAGNETIC FIELD INHOMOGENEITY
The B0 field inhomogeneity produced by differences in magnetic susceptibility (Section
1.1.3) shifts MR spectra along the frequency axis, causing the Z-spectrum to shift equivalently
along the saturation offset frequency axis. In the case of CEST-MRI where the measurements of
Z-spectral asymmetry are of interest, even small shifts in the positions of Z-spectra can result in
large changes in asymmetry calculations, rendering them inaccurate unless a B0 inhomogeneity
correction is applied. Because B0 field inhomogeneity laterally shifts the Z-spectrum by an
amount proportional to γΔB, the effect can be removed if the magnitude of the B0 field
inhomogeneity is known (Kim, Gillen et al. 2009).
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A number of procedures for correcting B0 field inhomogeneity have been demonstrated.
For sufficiently separated CEST and direct water saturation (DWS) effects, a simple polynomial
or spline fit is often applied and the minimum of the resulting fit assumed to be the center of the
Z-spectrum for asymmetry calculations (Zhou, Payen et al. 2003). Another method uses B0 field
inhomogeneity maps acquired with an appropriate MR acquisition sequence to shift the Zspectra; using a gradient echo acquisition with two different echo times, the magnitude of the B0
field inhomogeneity, ΔB0, is determined from the phase difference between the two images, as
Δ𝐵 =

𝜙(𝑇𝐸1 )−𝜙(𝑇𝐸2 )
𝛾(𝑇𝐸2 −𝑇𝐸1 )

(1.20)

where γ is the gyromagnetic ratio of the proton, TEi are the echo times, and the φ are the
accumulated phases at each echo time (Haacke, Brown et al. 1999). This procedure has been
applied to glycosaminoglycan CEST imaging (Wei, Jia et al. 2014). A technique known as water
saturation shift referencing (WASSR), determines the magnitude of the B0 field inhomogeneity
effect by collecting a pure DWS image (Kim, Gillen et al. 2009). This is accomplished by
applying a sufficiently weak RF saturation pre-pulse to minimize interference from both MT and
CEST effects. Since the resulting DWS is symmetric, the center frequency can be determined by
reflecting the Z-spectrum about 0 ppm and minimizing the difference between the acquired and
reflected Z-spectra.
The points of interest on the Z-spectra for calculating MTR asymmetry are determined by
the material exhibiting the CEST effect. The Z-spectra are collected at discrete frequency offsets,
however; MTR asymmetry analysis is performed as a post-processing procedure. After B0 field
inhomogeneity correction is, the discrete Z-spectral data must be interpolated to calculate the
MTR asymmetry values. Interpolation is commonly performed by fitting the Z-spectral data with
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high order polynomials (Jia, Abaza et al. 2011). Other studies have investigated fitting with
multiple Lorentzian functions with interaction cross-terms for multiple solute pools (Sun 2010).
1.7 PROSTATE CANCER AND MRI
In the United States, one in seven men is expected to develop prostate cancer during their
lifetimes. In 2015, there will be an estimated 220,800 new cases of prostate cancer and more than
27,500 related deaths, accounting for more than 25% of cancer incidences and 8.8% of cancer
related deaths in men (Siegel, Miller et al. 2015).
MRI often aids in the diagnosis and management of prostate cancer. Currently, multiparametric techniques are used including T1- and T2- weighted MRI, diffusion weighted MRI,
dynamic contrast-enhanced MRI, and MR spectroscopic imaging (Langer, van der Kwast et al.
2009, Hoeks, Barentsz et al. 2011).
1.8 BLADDER CANCER AND MRI
There are expected to be 74,000 new cases of bladder cancer and 16,000 related deaths in
the United States in 2015. Bladder cancer is three times more common in men than in women,
and is expected to account for 7% of all cancers in men and 4% of cancer deaths in men (Siegel,
Miller et al. 2015).
Multi-parametric MRI techniques are often performed to aid in the management of
bladder cancer. Contrast enhanced and diffusion weighted MRI have demonstrated the ability to
identify muscle invasion with high accuracy (Green, Durand et al. 2012). These techniques also
may find applications in evaluating and predicting response to chemotherapy (Nguyen, Jia et al.
2015).
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1.9 MOTIVATION FOR RESEARCH
Currently, CEST-MRI has no universally applied method of data analysis. Z-spectral data
are interpolated following B0 correction using a variety of methods. This lack of standard
procedure hinders comparison of results across multiple sites and studies, limiting the adoption
of MTRasym calculations as a clinically relevant quantitative imaging biomarker. Additionally, no
standard CEST-MRI phantoms exist to assess the performance of analysis procedures and
acquisition pulse sequences. The goal of this work was to evaluate curve fitting methods for Zspectral data analysis that are based to varying degrees on the physics of CEST-MRI.
Additionally, this work is to demonstrate the capability of MTRasym calculations based on a
selected model to distinguish tumor from healthy tissue.
1.10 HYPOTHESIS AND SPECIFIC AIMS
The hypothesis of this work was that independently fitting the upfield and downfield
components of the Z-spectrum with a partially physics-based model will be preferred to fitting
with high order polynomials based on the quality of fit. Quality of fit was assessed with both
phantom and prostate MR images. The best quality method was used to calculate MTRasym
values.
Aim 1: Compare the quality of fits between a separate upfield and downfield fitting
procedure and high order polynomial fitting procedure for a CEST-MRI phantom. A CEST-MRI
phantom was designed, built, and imaged. Z-spectral data were extracted from these images and
fit using a method with separate upfield and downfield components, as well as two high order
polynomial models. The small sample bias-corrected Akaike’s Information Criterion (AICc) was
calculated for each fitting procedure and used to identify a preferred method of curve fitting for
the phantom images.
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Aim 2: Compare the quality of fits between the separate upfield and downfield fitting
model and high order polynomial fitting models for CEST-MRI images of prostate cancer
patients. Z-spectral data were extracted from images of prostate cancer patients in different
regions of the prostate. The Z-spectral data were fit with a subset of the models tested in Aim 1.
The quality of these fits was compared using the small sample bias-corrected AICc, identifying a
preferred method of curve fitting for the patient images.
Aim 3: Apply the model to images of bladder cancer patients, and calculate the MTRasym
values to demonstrate capability of the model. Z-spectral data were extracted from images of
bladder cancer patients and fit using the preferred method of curve fitting identified in Aims 1
and 2. The Z-spectral fits were used to calculate MTRasym values in the different regions of the
phantom to demonstrate that the measures of MTRasym have the ability to distinguish bladder
cancer from normal bladder tissue.
1.11 OVERVIEW OF THE THESIS
The specific aims were used to demonstrate the efficacy of separately fitting the Zspectral components upfield and downfield from water resonance. Specifically, a preferred
method of curve fitting was identified using the AICc for both phantom images and prostate
cancer patient images, and this preferred method was applied to bladder cancer patient images to
demonstrate the utility of the preferred model.
Chapter 2 explains the methods and procedures used to test the hypothesis that fitting the
upfield and downfield components of the Z-spectra separately is preferable to fitting with a high
order polynomial, based on a combination of parametric parsimony and discrepancy between the
Z-spectral data and the fitting model. These methods and procedures include details regarding
the design and construction of the phantom, as well as the prostate cancer patient imaging
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technique. Chapter 2 also details the procedure of demonstrating the utility of the model by
distinguishing healthy bladder tissue from tumor with these measurements.
Chapter 3 details the results of phantom development as well as comparison of fitting
models. The preferred model for Z-spectral fitting was identified from the phantom study and the
retrospective patient study. Additionally, MTRasym measurements made using the preferred
model were applied to assess their ability to distinguish bladder cancer from healthy bladder
tissue.
Chapter 4 discusses the results, including the strengths and limitations of this work. This
chapter also includes a recommendation for future research directions based upon the outcomes
presented here.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Z-SPECTRAL CURVE FITTING METHOD – OVERVIEW
This study proposed a model which separately fits the upfield and downfield components
of the Z-spectra obtained in CEST-MRI experiments (Figure 2.1). The effects of DWS, MT, and
the Nuclear Overhauser Effect (NOE) are observed in the region of the Z-spectrum upfield from
water resonance. The effects of DWS, MT, and CEST are expected to be observed in the
downfield region of the Z-spectrum.

Figure 2.1: A sample Z-spectrum (open circles). Downfield from water, DWS, MT, and CEST
effects are expected, while upfield from water DWS, MT, and NOE effects are expected. The
DWS and MT components of this Z-spectrum are plotted and labeled.
The contribution from NOE is usually neglected in CEST-MRI measurements performed
at a field strength of 3 T, although it can become significant at higher field strengths; a term can
be added to account for NOW. NOE was not included in this work. A Lorentzian function was
used to describe DWS (Zaiß, Schmitt et al. 2011), and a function was chosen for MT depending
upon the material (Sections 2.1.1 and 2.1.2).
19

The downfield component of the Z-spectrum could potentially be modeled based on the
different effects which are present, similar to the upfield component. For instance, using a sum of
Lorentzian functions describing different solute pools with exchange terms could describe the
downfield component, including the CEST contribution (Sun 2010). In tissue, however, the
many different types of solute protons have overlapping regions of RF absorption, resulting in an
excessive number of fitting parameters relative to the available number of data points. To avoid
this, a polynomial was used to fit the downfield component.
These models combining the upfield and downfield components were referred to as the
“combination model” in this work. The models were identified by the order of polynomial used
to fit the downfield region of the Z-spectrum. For example, “6th order combination” would refer
to fitting the upfield region with the DWS and MT components (see Equation 2.1 or Equation
2.2) and the downfield region with a 6th order polynomial.
2.1.1 Z-SPECTRAL CURVE FITTING METHOD - PHANTOM
Previous studies demonstrated that Gaussian functions appropriately describe the MT
effect in agar (Morrison and Henkelman 1995). In Aim 1, MT in the phantom was provided by
agar, so the upfield components of the Z-spectra was fit to:
𝑆
𝑆0

=1−

2
𝐺
𝐴𝑤 ( 𝑤 )
2

2

𝐺
( 𝑤 ) +Δ𝜔2
2

1

𝛥𝜔 2

− 𝐴𝑏 exp [− (2) ( 𝐶 ) ]
𝑏

(2.1)

where Aw and Gw were the magnitude and full width at half maximum (FWHM), respectively, of
the Lorentzian describing DWS, Δω was the frequency offset from water resonance, Ab was the
magnitude of MT, and Cb was a constant, determined through curve fitting, describing the width
of the Gaussian function used to describe MT in agar.
The downfield region was fit to polynomial functions, the orders of which are discussed
in Section 2.3.5.
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2.1.2 Z-SPECTRAL CURVE FITTING METHOD - PATIENT
Although it has been demonstrated that super-Lorentzian functions are a good description
of MT in tissue, they are very broad relative to DWS and may be treated as constants in a small
range near water resonance. In Aims 2 and 3, MT is provided by the relatively immobile
macromolecules in tissue, so the upfield components of the Z-spectra were fit to:
𝑆
𝑆0

=1−

2
𝐺
𝐴𝑤 ( 𝑤 )
2

2
𝐺
( 𝑤 ) +Δ𝜔2

− 𝐴𝑏

(2.2)

2

where Aw and Gw were the magnitude and FWHM, respectively, of the Lorentzian describing
DWS, Δω was the frequency offset from water resonance, and Ab was the magnitude of MT.
2.2 MODEL SELECTION CRITERIA
The preferred fitting model was identified using the small sample bias-corrected Akaike
Information Criterion (AICc). The AICc compares the quality of proposed fitting models for a
set of data, with the preferred model having the most negative AICc value (Hurvich and Tsai
1989). The AICc is calculated based on the residual sum of squares (RSS), the sample size (n),
and the number of fitting parameters in the proposed model (m), according to the equation:
𝑅𝑆𝑆

𝐴𝐼𝐶𝑐 = 𝑛 ln (

𝑛

1+𝑚/𝑛

) + 𝑛 1−(𝑚+2)/𝑛

(2.3)

The AICc value was computed in IDL (Version 8.2, Exelis Visual Information Solutions)
for each of the models tested following the curve fitting procedure. A pairwise Student’s t-test
was performed in the statistical analysis software R (Version 3.1.0, R Development Core Team)
to determine if the average AICc values were statistically significantly different for the models.
The preferred model will be identified as having the most negative average AICc; in cases where
two models did not have significantly different average AICc values, the most negative
maximum AICc was used.
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2.3 AIM 1, APPLICATION OF MODEL TO CEST-MRI PHANTOM IMAGES
2.3.1 PHANTOM MATERIAL SELECTION
To create a CEST-MRI phantom, materials were selected with RF absorption covering a
range of offset frequencies. The materials and their offset frequencies are listed in Table 2.1. All
of the materials were incorporated in 2% agar to provide a broad MT effect due to immobile
macromolecules, allowing the phantom to exhibit CEST effects in the presence of MT to mimic
the situation that would be seen in vivo. Additionally, the agar was prepared with 0.01 M
phosphate-buffered saline (PBS) with a pH of 7.4 to represent physiological. Three
concentrations (Table 2.1) were selected for each material, either to match concentrations that
have been used previously in literature or to use concentrations that are representative of
physiological conditions.
Table 2.1: Concentrations of materials included in the CEST-MRI phantom and the
corresponding frequency offset at which the CEST effects are expected.
Materialref
Concentration A Concentration B Concentration C Frequency Offset
[mM]
[mM]
[mM]
[ppm]
1 *Glycogen1,2 10
50
100
1.2
2
2 *Glucose
10
50
100
1.3 - 2
3 *Creatine3
10
25
50
1.8
4
4 *L-Lysine
1
10
100
3.0
5 *NH4Cl5
100
500
1000
2.4
6
6 *Choline
5
15
50
1.0
5
7 Agar
2%
4%
6%
MT
* indicates the material was mixed in 2% agar.
1 Taylor 1996
2 van Zijl 2007
3 Kogan 2014
4 Ward 2000
5 Desmond 2012
6 Chen 2006
2.3.2 PHANTOM DEVELOPMENT
The selected materials were built into an existing MRI phantom (model MRI-R01, Data
Spectrum Corporation, Durham, NC, USA). This cylindrical, water-filled phantom (Figure 2.2)
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included plastic inserts which held twenty-one vials of 30 mL total volume each. The vials were
separated into three groups of seven, shown in Figure 2.2 (right) and Figure 2.3.

Figure 2.2: The Data Spectrum Corporation's MRI phantom. The phantom includes inserts for
spatial resolution, slice thickness, slice profile, linearity, and quantitative imaging (left), though
only the quantitative imaging insert (right) is of interest to this study.

Figure 2.3: The layout of vials in the CEST phantom. Numbers 1-6 correspond to the materials
as numbered in Table 2.1, while the letters A, B, and C identify the low concentrations,
intermediate concentrations, and high concentrations, respectively. Vial 7 in each group
contained agar alone in concentrations of 2% (7A), 4% (7B), or 6% (7C).
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Each group of vials contained all six of the materials; one group was the lowest
concentrations, one was the intermediate concentrations, and one was the highest concentrations.
In each group, the vial closest to the central axis of the phantom was glycogen, with the
remaining materials placed counterclockwise in the order of glucose, creatine, L-lysine, NH4Cl,
and choline (Figure 2.3). The central vial of each group contained the agar with a concentration
of 2%, 4%, or 6%; the relative concentrations corresponded to the relative material
concentrations, so that the groups could be identified by the magnitude of the MT effect in the
agar vials.
The vials were glass liquid scintillation vials. The vials were filled with 0.36 g of
powdered agar, 0.11 g of 5% w/v NaN3 as an antibacterial agent (Hattori, Ikemoto et al. 2013),
and the required mass of material to meet the concentrations listed in Table 2.1. These were
mixed in PBS to a final mass of 18 g. Each mixture was heated in a water bath at 90°C for 20
minutes; the mixture was stirred halfway through the heating period. After heating, the mixtures
were stirred again; the vials were capped and placed on ice to solidify.
2.3.3 PHANTOM IMAGING PROCEDURE
T1-weighted and T2-weighted images were acquired to assess the properties of the
phantom. The images were acquired using a 4 channel head coil on a 3 T MR system (Signa, GE
Healthcare, Waukesha, WI). T1 mapping was performed using an inversion recovery technique.
Images were acquired with a fast spin echo pulse sequence with the following sequence
parameters: a TE of 15 ms; a TR of 7500 ms; multiple TIs of 1900 ms, 1600 ms, 1300 ms, 800
ms, 600 ms, and 500 ms; an echo train length of 16; receiver bandwidth of 50 kHz; a FOV of 30
× 30 cm2; a slice thickness of 10 mm; a NEX of 1; acquisition matrix of 256 × 256; and the
frequency encoding direction R/L. Post-processing for the T1 map was performed using the
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MRMap software (Version 1.4, Daniel Messroghli) written in IDL (Figure 2.4) and freely
available for download online (http://sourceforge.net/projects/mrmap/).
T2 measurements were made using a multiple echo time technique from images acquired
with a fast spin echo pulse sequence with the following sequence parameters: TEs of 7.3 ms,
14.2 ms, 21.3 ms, 28.5 ms, 35.6 ms, 42.7 ms, 49.8 ms, and 56.9 ms; a TR of 1650 ms; a receiver
bandwidth of 62.25 kHz; a FOV of 30 × 30 cm2; a NEX of 1; an acquisition matrix of 320 × 256;
and a frequency encoding direction of R/L. Post-processing for the T2 calculations was
performed using the Dynamic Magnetic Resonance Imaging Software Tool (Version OSU-5.0,
Division of Imaging Research, The Ohio State University) written in IDL (Figure 2.5).

Figure 2.4: The software MRMap (Version 1.4, Daniel Messroghli) was used to create T1 maps,
performing the required curve fitting for each pixel.
For CEST-MR imaging, the phantom was imaged on a 3 T MR system (Achieva, Philips
Healthcare, Cleveland, OH) using a 32 channel digital head coil. Images were acquired using a
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2D multiple-shot turbo spin echo sequence (msTSE) with a TR of 3000 ms, TE of 26 ms, slice
thickness of 6 mm, acquisition matrix size of 112 × 100, field of view of 225 × 225 mm2, TSE
factor of 20, NSA of 1, and flip angle of 90˚. A train of RF saturation pre-pulses consisting of 16
block pulses each 29 ms in length was applied at frequency offsets from 8 ppm to -8 ppm in 0.5
ppm increments. An additional image was acquired without saturation as a reference. A set of
CEST-MR images was acquired for each of the following saturation amplitudes: 1.6 µT, 2.4 µT,
3.2 µT, and 4.0 µT.

Figure 2.5: The Dynamic Magnetic Resonance Imaging Software Tool (Version OSU-5.0,
Division of Imaging Research, The Ohio State University) was used to calculate T2 values in
user-defined regions of the phantom.
B0 field inhomogeneity maps were collected after CEST-MR imaging using a 2D fast
field echo (FFE) technique with the following sequence parameters: a TR of 15 ms; ΔTEs of 1
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ms, 3 ms, 5 ms, 7 ms, and 9 ms; a slice thickness of 6 mm; an acquisition matrix size of 112 ×
112; a field of view of 225 × 225 mm2; NSA of 1; and a flip angle of 8˚. Reconstruction was
performed automatically with the MR system software.
2.3.4 Z-SPECTRAL DATA COLLECTION
The Dynamic Magnetic Resonance Imaging Software Tool was used to extract the Zspectral data from the CEST-MR images of the phantom. ROIs were placed in the center of each
of the 21 materials with margins large enough to avoid any pixels containing the glass walls of
the liquid scintillation vials. For each of the saturation amplitudes, the average signal intensity in
each region collected for the 33 CEST-MR images, as well as the average signal intensity in the
absence of saturation and the average B0 field inhomogeneity.
2.3.5 Z-SPECTRAL CURVE FITTING
Prior to fitting the Z-spectral data, the frequency axis coordinates were corrected for B0
inhomogeneity by subtracting the average B0 value (in ppm) from the acquired frequency offsets
(8 ppm to -8 ppm in 0.5 ppm increments). This corrected the lateral shift of the Z-spectra due to
the B0 field inhomogeneity.
The indices of the B0-corrected positive and negative frequency offsets were then
identified. Data points with negative frequency offsets were fit to Equation 2.2. When
subsequently fitting the downfield (positive) frequency offsets, the fitted zero-frequency value
from the upfield fit was included with the downfield offset data. Including this fitted upfield
value in the downfield fit caused the upfield and downfield fits to meet at the 0 ppm frequency
offset.
Z-spectral fitting was performed in IDL using the nonlinear least squares curve fitting
package MPFIT (Markwardt 2009). Two models from literature, a 20th order polynomial and a
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12th order polynomial, were fit to Z-spectral data for each ROI. The combination model proposed
in Section 2.1 was fit with downfield polynomials of 3rd, 4th, 5th, 6th, 7th, and 8th orders to
determine the preferred degree. Data points with signal intensities less than 5% of the signal in
the absence of saturation occurred near the center of the Z-spectra, and were not included in the
fitting procedure because of the poor signal-to-noise ratio of this data. For each of the 8 models
applied, the AICc was calculated from the fitted Z-spectra in IDL using Equation 2.3.
2.3.6 ASSESSMENT OF MODEL PERFORMANCE
Performance of the models was assessed using the AICc values calculated after the curve
fitting process. The preferred curve fitting model produced the most negative average AICc
value.
2.4 AIM 2, APPLICATION OF MODEL TO PROSTATE CANCER PATIENT IMAGES
2.4.1 PROSTATE CANCER PATIENT POPULATION
Eighteen patients with biopsy-proven prostate cancer were included in this retrospective
study. Thirteen of these patients underwent prostatectomy, while five received radiation therapy.
An additional two volunteers were included. The average age of those enrolled in the study was
61.1 years (range, 51 to 76). Tumor staging information was available from final pathology
reports for the 13 patients who underwent prostatectomy; the distribution of these tumor stages
was: two T2a, one T2b, seven T2c, and three T3a. The study was approved by an institutional
review board (IRB) at The Ohio State University and was compliant with the Health Insurance
Portability and Accountability Act (HIPAA). Informed consent was obtained from each patient.
2.4.2 PROSTATE CANCER PATIENT IMAGING
All MR images were acquired with a 3 T MR system (Achieva, Philips Healthcare) using
a 32 channel phased array coil. Images were selected based on the location of the tumor within

28

the prostate; CEST-MRI images were acquired using a single slice, single-shot turbo spin echo
(ssTSE) pulse sequence with a TR of 4000 ms, TE of 56 ms, slice thickness of 6 mm, acquisition
matrix size of 80 × 65, field of view of 140 × 140 mm2, TSE factor of 64, NSA of 1, and flip
angle of 90˚. The RF saturation pre-pulse consisted of sixteen block pulses 31 ms in duration
with saturation amplitudes of 1.6 µT, 2.4 µT, 3.2 µT, and 4.0 µT. For each of the saturation
amplitudes, 33 images were acquired with the saturation pre-pulse applied at offset frequencies
from 8 ppm to -8 ppm in 0.5 ppm increments. An additional image was acquired without
saturation as a reference. The acquisition time for this process was 3.5 minutes. Additionally, a
B0 map was obtained for each patient using a 2D fast field echo (FFE) sequence with a TR of 48
ms, TE1 of 1.58 ms, TE2 of 4.1 ms, slice thickness 6 mm, acquisition matrix of 80 × 65, field of
view of 140 × 140 mm2, NSA of 6, flip angle of 20˚, and acquisition time of 19.5 s. The B0 map
was created using the scanner’s automatic reconstruction.
2.4.3 PROSTATE CANCER PATIENT Z-SPECTRAL DATA COLLECTION
Pathology slides were created from tissue samples from patients who underwent
prostatectomy. Experienced uropathologists identified the location and extent of the tumors. The
slides were digitized to create images that could be co-registered with MR images, and regions of
interest (ROIs) for the peripheral zone (PZ), central gland (CG), and tumor were created by an
experienced medical physicist. Patients receiving radiation therapy had ROIs delineated by the
physicist based on T2-weighted imaging and biopsy reports. An example of a pathologic slide
with the marked tumor location and the resulting tumor ROI overlaid onto the CEST-MR image
is shown in Figure 2.6.
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Figure 2.6: The pathologic slide created by the uropathologist (a) and the corresponding ROI
drawn in the CEST-MR image (b).
Z-spectral data were extracted from the 232 resulting ROIs using the Dynamic Magnetic
Resonance Imaging Software Tool. The average signal intensities for each of the 33 CEST-MR
images, and the image in the absence of saturation, were recorded. The average B0 value from
the B0 map was recorded.
2.4.4 Z-SPECTRAL CURVE FITTING
Prior to fitting the Z-spectral data, B0 field inhomogeneity correction was performed. Zspectral fitting was performed in as described in Section 2.3.5. The 20th and 12th order
polynomials were used to fit the complete set of Z-spectral data. The combination models were
fit with downfield polynomials of 3rd, 4th, 5th, and 6th order. These orders were selected based on
the phantom results (see Section 3.1.3).
2.4.5 ASSESSMENT OF MODEL PERFORMANCE
Performance of the models was assessed using the AICc values calculated after curve
fitting. The curve fitting model providing the most negative average AICc values was identified.
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2.5 AIM 3, APPLICATION OF MODEL TO BLADDER CANCER PATIENT IMAGES
2.5.1 BLADDER CANCER PATIENT POPULATION
25 patients (19 male, 6 female) with biopsy-proven bladder cancer were enrolled in this
study. The patients had an average age at the time of baseline imaging of 64 years (standard
deviation, 12 years), and an average weight of 83.7 kg (standard deviation, 19.3 kg). The study
was approved by an IRB at The Ohio State University and was HIPAA compliant. Informed
consent was obtained from each patient.
2.5.2 BLADDER CANCER PATIENT IMAGING
The patients were imaged on a 3 T MR system (Achieva, Philips Healthcare) using a 32
channel cardiac surface coil. Images were acquired with a single-shot TSE sequence with the
following parameters: a TR of 6100 ms; a TE of 56 ms; a TSE factor of 47; a NSA of 1; an
acquisition matrix of 80 × 65; a FOV of 140 × 140 mm2; a slice thickness of 6 mm; and a flip
angle of 90˚. The acquired slice was positioned to include the tumor with the aid of T2-weighted
anatomical images. The saturation pre-pulse consisted of 16 block pulses each 29 ms in duration
with a saturation amplitude of 4.0 µT; 33 CEST-MR images were acquired with the saturation
pre-pulse applied at frequency offsets from 8 ppm to -8 ppm in 0.5 ppm increments. An
additional image was acquired in the absence of saturation. The acquisition time for the CESTMR images was 3.5 minutes. A B0 field inhomogeneity map was acquired using a dual echo FFE
technique with the following sequence parameters: a TR of 69.6 ms; TE of 2 ms and 10 ms; a
NSA of 4; an acquisition matrix of 80 × 65; a FOV of 140 × 140 mm2; a slice thickness of 6 mm;
and a flip angle of 20˚. The acquisition time was 25 seconds. Reconstruction was performed
automatically by the MR system software.
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2.5.3 Z-SPECTRAL DATA COLLECTION
For each bladder cancer patient, ROIs for normal bladder wall (NBW) and tumor were
delineated based on anatomical T2-weighted images by an experienced medical physicist. The Zspectral data in each ROI, including the average B0 value from the field inhomogeneity map,
were collected with the Dynamic Magnetic Resonance Imaging Software Tool.
2.5.4 Z-SPECTRAL CURVE FITTING
Prior to curve fitting, the B0 inhomogeneity correction discussed in previous sections was
applied. The upfield component was fit to Equation 2.1, and the downfield component was fit to
a 4th order polynomial, which was determined to be the preferred Z-spectral curve fitting model
for phantom images with a saturation amplitude of 4.0 µT (see Section 3.2 and Section 4.4). Data
points were excluded from the fitting process if the signal average at that frequency offset was
less than 5% of the signal intensity in the absence of saturation, to avoid data points with a low
signal-to-noise ratio.
2.5.5 DISTINGUISHING NORMAL BLADDER WALL FROM CANCER
The shifted, fitted Z-spectra were used to calculate MTRasym at frequency offsets of 2.0
ppm and 3.5 ppm, corresponding to the amine and amide protons, respectively. A two-tailed,
paired Student’s t-test was used to test for significant differences in the MTRasym(2.0 ppm) and
MTRasym(3.5 ppm) quantities between the NBW and tumor regions. A Shapiro-Wilk test was
performed to confirm that the data was normally distributed. These tests were performed using
the statistical analysis software, R (Version 3.1.0, R Development Core Team). P-values less
than 0.05 were considered significant for all tests.
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CHAPTER 3: RESULTS
3.1 RESULTS FOR AIM 1: PHANTOM MODEL SELECTION
3.1.1 PHANTOM PROPERTIES
Average values for T1 and T2 relaxation times and the associated standard deviations and
standard errors are contained in Table 3.1. Standard deviations for T1 are the standard deviation
of pixel values from the T1 map, while standard errors for T2 measurements are from the
Dynamic Magnetic Resonance Imaging Software Tool.
Table 3.1: Average T1 and T2 relaxation times and the associated standard deviations (σT1) or
standard errors (SET2) for the regions of the phantom. Table 2.1 contains the concentration
values for A, B, and C.
Material Concentration T1 (ms)
σT1 (ms)
T2 (ms)
SET2 (ms)
Agar
A
2360
170
136
6
B
1910
540
66
2
C
1710
120
56
2
Choline
A
2370
140
125
7
B
2410
150
136
6
C
2410
170
145
6
Creatine A
2500
300
190
13
B
2340
160
153
6
C
2550
430
167
17
Glucose
A
2410
150
146
6
B
2320
120
115
5
C
2350
150
112
4
Glycogen A
2410
120
131
8
B
2240
110
121
5
C
2060
390
114
4
Lysine
A
2400
310
129
2
B
2370
260
115
7
C
2480
660
154
27
NH4Cl
A
2480
210
130
6
B
2630
420
101
6
C
2660
605
99
8
Water
2960
180
1030
520
The B0 field inhomogeneity maps are shown in Figure 3.1. The measured B0 field
inhomogeneity increased with increasing difference in echo times. The B0 field inhomogeneity
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map with a ΔTE of 5 ms was used for the CEST-MR image post processing because it was the
largest echo time difference that did not produce noticeable artifacts due to large phase
differences.

Figure 3.1: The B0 field inhomogeneity maps created with echo time differences of (a) 1 ms, (b)
3 ms, (c) 5 ms, (d) 7 ms, and (e) 9 ms. A phase wrapping artifact is evident for echo time
differences of 7 ms and 9 ms.
3.1.2 PHANTOM CURVE FITTING RESULTS
Representative examples of the curve fitting results for CEST-MR Z-spectra with a
saturation amplitude of 1.6 µT are shown in Figure 3.2. The Z-spectra from a low saturation
amplitude were more sharply peaked than those from higher saturation amplitudes. This caused
the combination models using low order polynomials to perform poorly visually in the region of
the Z-spectrum upfield from water resonance, indicated by the arrow in Figure 3.2a. The
combination models using higher order polynomials perform well visually, though the 8th order
combination model shows some oscillation near the end of the fitting interval, indicated by the
arrow in Figure 3.2b. The two polynomial models both experience significant oscillation near the
ends of the fitting intervals, indicated by the arrows in Figure 3.2c and Figure 3.2d.
Representative examples of the curve fitting results for CEST-MR Z-spectra with a
saturation amplitude of 4.0 µT are shown in Figure 3.3. At this high saturation amplitude, the Zspectra became less sharply peaked. The broader shape of the Z-spectra decreased the size of the
oscillations near the edges of the interval for all models, and in many cases eliminated all
oscillations. The visual performance of the combination model using a low order polynomial
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improved as the saturation amplitude increased, as shown by the difference between Figure 3.2a
and Figure 3.3a. In some cases, the combination models using high order polynomials had large
deviations from the expected shape due to the excluded data points around 0 ppm, indicated by
the arrow in Figure 3.3b. The 12th order polynomial performed well visually at this high
saturation amplitude, shown in Figure 3.3c. The 20th order polynomial exhibited oscillations
even at this high saturation amplitude, shown in Figure 3.3d.

Figure 3.2: The Z-spectrum for Glucose concentration C with a saturation amplitude of 1.6 µT fit
with (a) the 3rd order combination model, (b) the 8th order combination model, (c) the 12th order
polynomial model, and (d) the 20th order polynomial model.
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Figure 3.3: The Z-spectrum for Glucose concentration C with a saturation amplitude of 4.0 µT fit
with (a) the 3rd order combination model, (b) the 8th order combination model, (c) the 12th order
polynomial model, and (d) the 20th order polynomial model.
3.1.3 PHANTOM MODEL SELECTION
The distributions of AICc values for the Z-spectra with a saturation amplitude of 1.6 µT
are displayed as boxplots in Figure 3.4. The average AICc values are listed in Table 3.2, ordered
by increasing average AICc. The combination models utilizing low order polynomials did not
perform well at this saturation amplitude using the AICc as a metric due to a high residual sum
of squares. The large AICc of the high order polynomial fitting was due to the large number of
fitting parameters rather than the goodness of fit. The 6th order combination was the preferred
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model for the 1.6 µT saturation amplitude as it has the most negative maximum AICc of the
subset of models with the most negative but statistically indistinguishable average AICc.

Figure 3.4: The distributions of AICc values averaged over all material concentrations with the
saturation amplitude of 1.6 µT. The averages indicated on the boxplots are median values. *
indicates the preferred model.
Table 3.2: AICc results of the models for the saturation amplitude of 1.6 µT, ordered by
increasing average AICc.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
th
1
Combination, 6 order
-263.0
24.3
-317.4
-229.9
th
2
Combination, 7 order
-261.5
24.6
-316.2
-224.0
3
Combination, 8th order
-261.4
23.7
-310.8
-223.9
th
4*
Combination, 5 order
-240.9
17.1
-279.6
-210.1
5**
Polynomial, 12th order
-200.7
23.5
-248.4
-169.1
th
6**
Combination, 4 order
-190.8
16.6
-240.1
-174.1
7**
Combination, 3rd order
-158.7
12.0
-197.7
-148.5
th
8**
Polynomial, 20 order
-133.9
32.2
-184.9
-49.9
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
The distributions of AICc values for the Z-spectra with a saturation amplitude of 2.4 µT
are displayed as boxplots in Figure 3.5. The average AICc values for each model and the
associated standard deviations, minimums, and maximums are listed in Table 3.3. The 4th and 5th
37

order combination models showed lower average AICc compared to the 1.6 µT saturation
amplitude Z-spectra, with the 5th order combination having the most negative average AICc. As
with the 1.6 µT saturation amplitude, the poor performance of the 20th order polynomial model
was due to the large number of fitting parameters relative to the number of data points, while the
poor performance of the 3rd order combination model was due to the relatively high sum of
squared residuals. The 5th order polynomial model was the preferred model for the 2.4 µT
saturation amplitude because it had the most negative maximum AICc of the subset of models
with the most negative but statistically indistinguishable average AICc.

Figure 3.5: The distributions of AICc values averaged over all material concentrations with the
saturation amplitude of 2.4 µT. The averages indicated on the boxplots are median values. *
indicates the preferred model.
The distributions of AICc values for Z-spectra with a saturation amplitude of 3.2 µT are
displayed as boxplots in Figure 3.6. The average AICc values for each model are listed in Table
3.4. The relatively large saturation amplitude improved the performance of the combination
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model relying on the lower order polynomials to fit the region of the Z-spectra upfield from
water resonance. The average AICc values for the 20th order polynomial continued to increase as
more data points fell below the exclusion threshold for the fitting procedure which further
increased the ratio of fitting parameters to the number of data points. The 6th order combination
model was the preferred model for the 3.2 µT saturation amplitude because it had the most
negative maximum AICc of the subset of models with the most negative but statistically
indistinguishable average AICc.
Table 3.3: AICc results of the models for the saturation amplitude of 2.4 µT, ordered by
increasing average AICc.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
1
Combination, 5th order
-248.3
20.1
-282.1
-217.8
th
2
Combination, 6 order
-246.2
20.4
-279.8
-212.1
3
Combination, 7th order
-245.8
20.1
-277.5
-205.2
th
4*
Combination, 8 order
-241.3
20.9
-273.6
-199.7
5**
Polynomial, 12th order
-235.0
21.5
-273.9
-176.1
th
6**
Combination, 4 order
-227.5
10.5
-246.5
-206.9
rd
7**
Combination, 3 order
-175.3
16.0
-232.9
-160.9
8**
Polynomial, 20th order
-79.2
34.9
-168.4
-12.0
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
The distributions of AICc values for the Z-spectra with a saturation amplitude of 4.0 µT
are displayed as boxplots in Figure 3.7. The average AICc values for each model are listed in
Table 3.5. The performance of the combination models using low order polynomials improved
further at the large saturation amplitude, with the 5th order combination model having the most
negative average AICc value and the 4th order combination having the most negative maximum
AICc value. The AICc values for the 20th order polynomial continued to increase with increasing
saturation amplitude as more data points fell below the exclusion threshold and the ratio of
fitting parameters to data points increased further. The 4th order combination was the preferred
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model because there was no significant difference (p > 0.05) between the average AICc value for
the 4th order combination and 6th order combination models, but the 4th order combination model
had the most negative maximum AICc value.

Figure 3.6: The distributions of AICc values averaged over all material concentrations with the
saturation amplitude of 3.2 µT. The averages indicated on the boxplots are median values. *
indicates the preferred model.
Table 3.4: AICc results of the models for the saturation amplitude of 3.2 µT, ordered by
increasing average AICc.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
th
1
Combination, 6 order -237.3
17.1
-264.3
-200.7
th
2
Combination, 7 order -236.4
21.0
-275.4
-194.8
3
Combination, 4th order -233.9
16.1
-253.5
-198.5
th
4
Combination, 5 order -230.6
15.9
-260.8
-196.4
5
Combination, 8th order -230.6
22.3
-275.3
-186.9
th
6
Polynomial, 20 order
-227.5
24.7
-274.7
-176.4
7**
Combination, 3rd order -197.0
16.7
-249.5
-178.1
th
8**
Polynomial, 20 order
-41.9
68.1
-143.0
186.3
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
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Figure 3.7: The distributions of AICc values averaged over all material concentrations with the
saturation amplitude of 4.0 µT. The averages indicated on the boxplots are median values. *
indicates the preferred model.
Table 3.5: AICc results of the models for the saturation amplitude of 4.0 µT, ordered by
increasing average AICc.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
th
1
Combination, 5 order -229.9
23.6
-266.5
-178.7
th
2
Combination, 4 order -229.3
22.4
-270.3
-184.3
3
Combination, 6th order -228.1
25.3
-263.4
-173.7
th
4
Combination, 7 order -222.3
26.0
-262.1
-168.3
5
Polynomial, 12th order
-221.2
35.9
-291.2
-149.5
th
6
Combination, 8 order -215.9
25.2
-254.3
-167.0
7**
Combination, 3rd order -211.5
16.1
-238.2
-179.5
th
8**
Polynomial, 20 order
105.1
201.3
-53.7
920.3
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
The distributions of AICc values for the combination of all saturation amplitudes are
displayed as boxplots in Figure 3.8. The average AICc values for the combination of all
saturation amplitudes are listed in Table 3.6. Although the model with the most negative AICc
value was the 6th order combination, there was no significant difference (p > 0.05) between AICc
values for the 5th, 6th, 7th, and 8th order combination models. Because of this, the 5th order
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combination was identified as the preferred model because it had the most negative maximum
AICc value of that group of models.

Figure 3.8: The distributions of AICc values for all of the fitting models tested for the CESTMRI phantom at all saturation amplitudes. * indicates the preferred model.
Table 3.6: AICc results of the models for all saturation amplitudes, ordered by increasing
average AICc.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
th
1
Combination, 6 order -243.7
25.2
-317.4
-173.7
2
Combination, 7th order -241.5
26.8
-316.2
-168.3
th
3
Combination, 5 order -237.4
20.5
-282.1
-178.7
4
Combination, 8th order -237.3
28.1
-310.8
-167.0
th
5*
Polynomial, 12 order
-221.1
29.4
-291.2
-149.5
th
6*
Combination, 4 order -220.4
24.1
-270.3
-174.1
7**
Combination, 3rd order -185.6
25.3
-249.5
-148.5
th
8**
Polynomial, 20 order
-37.5
139.2
-184.9
920.3
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
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The preferred model selected by the AICc depended on the amplitude of the saturation
pre-pulse. Table 3.7 lists the preferred fitting model for each of the saturation amplitudes tested.
A combination models was preferred for all saturation amplitudes tested, and the order of the
polynomial used for the portion of the Z-spectrum upfield from water resonance decreased with
increasing saturation amplitude.
Table 3.7: The preferred fitting models for the CEST-MRI phantom images as selected by AICc
for each of the saturation amplitudes tested.
Saturation Amplitude
Preferred Model
1.6 µT

6th Order Combination

2.4 µT

5th Order Combination

3.2 µT

6th Order Combination

4.0 µT

4th Order Combination

All Amplitudes

5th Order Combination

3.2 RESULTS FOR AIM 2: MODEL SELECTION WITH PATIENT IMAGES
3.2.1 PROSTATE CANCER PATIENT CURVE FITTING RESULTS
A representative sample of the curve fitting results for Z-spectra acquired from the
prostate cancer patient images with a saturation amplitude of 1.6 µT is plotted in Figure 3.9, with
deviations from the data indicated with arrows. As with Z-spectra from phantom images, those
acquired with low saturation amplitudes were more sharply peaked and experienced significant
oscillation near the edge of the fitting interval. The low order combination models did not
perform well when the Z-spectra were sharply peaked, and all of the models experienced at least
some deviations.
A representative sample of the curve fitting results for a Z-spectrum acquired from the
prostate cancer patient images with the saturation amplitude of 4.0 µT is plotted in Figure 3.10.
The increased saturation amplitude increased the width of the DWS contribution. The 3rd order
combination model appeared to have inadequacies at this saturation amplitude, indicated by the
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arrow in Figure 3.10a, while the higher order combination models, shown in Figure 3.10b,
performed well visually. Oscillations near the edge of the interval were greatly reduced for the
12th order polynomial model, shown in Figure 3.10c. The 20th order polynomial, shown in Figure
3.10d, exhibited oscillations near the edge of the interval for this saturation amplitude.

Figure 3.9: The Z-spectrum of the central gland region of the prostate from an image set acquired
with a saturation amplitude of 1.6 µT. The Z-spectrum was fit with (a) the 3rd order combination
model, (b) the 6th order combination model, (c) the 12th order polynomial model, and (d) the
20th order polynomial model.
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Figure 3.10: The Z-spectrum of the central gland region of the prostate from an image set
acquired with a saturation amplitude of 4.0 µT. The Z-spectrum was fit with (a) the 3rd order
combination model, (b) the 6th order combination model, (c) the 12th order polynomial model,
and (d) the 20th order polynomial model.
3.2.2 PATIENT MODEL SELECTION
The distributions of AICc values for the Z-spectra with a saturation amplitude of 1.6 µT
are displayed as boxplots in Figure 3.11. The average AICc for each model is listed in Table 3.8,
ordered by increasing average AICc. The combination models outperformed the high order
polynomial models using the AICc as a metric due to the polynomials’ high ratio of fitting
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parameters to the number of data points, though this is not visually apparent in Figure 3.9. The
5th and 6th order combination models outperformed the 3rd and 4th order combination models due
to their smaller residual sums of squares. The 6th order combination was the preferred model for
the 1.6 µT saturation amplitude because it had the most negative average AICc.

Figure 3.11: The distributions of AICc values for all regions of the prostate with a saturation
amplitude of 1.6 µT. The averages indicated on the boxplots are median values.* indicates the
preferred model.
Table 3.8: AICc results of the models for the saturation amplitude of 1.6 µT for the prostate
cancer patient images.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
th
1
Combination, 6 order -200.9
23.2
-243.3
-141.8
2*
Combination, 5th order -189.6
20.4
-227.6
-138.2
th
3**
Combination, 4 order -177.3
20.5
-228.0
-123.1
4**
Combination, 3rd order -176.5
21.8
-224.2
-124.2
th
5**
Polynomial, 12 order
-151.7
17.7
-193.1
-113.2
th
6**
Polynomial, 20 order
-120.7
30.9
-165.2
-42.2
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
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The distributions of AICc values for the Z-spectra with a saturation amplitude of 2.4 µT
are displayed as boxplots in Figure 3.12. The average AICc for each model is listed in Table 3.9,
ordered by increasing average AICc. The combination models outperformed the 20th order
polynomial model, though the 12th order polynomial model outperformed both the 3rd and 4th
order combination models. The 5th order combination was the preferred model for a 2.4 µT
saturation amplitude because it had the smallest maximum AICc of the subset of models with the
most negative but statistically indistinguishable average AICc.

Figure 3.12: The distributions of AICc values for all regions of the prostate with a saturation
amplitude of 2.4 µT. The averages indicated on the boxplots are median values. * indicates the
preferred model.
The distributions of AICc values for the Z-spectra with a saturation amplitude of 3.2 µT
are displayed as boxplots in Figure 3.13. The average AICc values for the saturation amplitude
of 3.2 µT are listed in Table 3.10, ordered by increasing average AICc. As saturation amplitude
increased, the Z-spectra broadened, and the performances of the low order polynomials within
the combination models improved, as seen in Figure 3.10. The visual performance improvement
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at higher saturation amplitudes seen for the 12th order polynomial model was reflected in the
AICc values. The 4th order combination was identified as the preferred model because it had the
most negative maximum AICc value of the subset of models with the most negative but
statistically indistinguishable average AICc.
Table 3.9: AICc results of the models for the saturation amplitude of 2.4 µT for the prostate
cancer patient images.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
1
Combination, 5th order -202.6
20.5
-240.3
-158.6
th
2
Combination, 6 order -200.3
19.6
-237.9
-154.7
th
3
Polynomial, 12 order
-195.1
24.7
-243.7
-143.4
4*
Combination, 4th order -193.6
19.4
-236.9
-153.0
rd
5**
Combination, 3 order -177.2
15.4
-212.5
-141.3
6**
Polynomial, 20th order
-122.7
27.5
-183.2
-58.7
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.

Figure 3.13: The distributions of AICc values for all regions of the prostate with a saturation
amplitude of 3.2 µT. The averages indicated on the boxplots are median values. * indicates the
preferred model.
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Table 3.10: AICc results of the models for the saturation amplitude of 3.2 µT for the prostate
cancer patient images.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
th
1
Combination, 4 order -204.9
24.1
-251.6
-149.1
2
Combination, 5th order -203.8
23.7
-250.2
-147.2
th
3
Combination, 6 order -200.8
23.4
-246.9
-144.5
th
4
Polynomial, 12 order
-200.7
27.3
-263.4
-133.1
5**
Combination, 3rd order -188.6
18.2
-223.8
-138.3
th
6**
Polynomial, 20 order
-129.5
30.7
-186.9
-54.8
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
The distributions of AICc values for the Z-spectra with a saturation amplitude of 4.0 µT
are displayed as boxplots in Figure 3.11. The average AICc values are listed in Table 3.12.
Though there were no statistically significant differences in average AICc value between the 3 rd,
4th, 5th, or 6th combination models or 12th order polynomial model, the 3rd order combination
model was preferred because it has the most negative maximum AICc.

Figure 3.14: The distributions of AICc values for all regions of the prostate with a saturation
amplitude of 4.0 µT. The averages indicated on the boxplots are median values. * indicates the
preferred model.
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The distributions of AICc values for the Z-spectra at all saturation amplitudes are
displayed as boxplots in Figure 3.15, and the average AICc values for all saturation amplitudes
are listed in Table 3.12. There was no significant difference in average AICc values between the
5th and 6th order combination models. The preferred model considering all saturation amplitudes
was the 6th order combination model, which had the smallest maximum AICc between the subset
of models with the most negative but statistically indistinguishable average AICc.
Table 3.11: AICc results of the models for the saturation amplitude of 4.0 µT for the prostate
cancer patient images.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
1
Combination, 4th order -208.9
23.1
-244.2
-146.9
th
2
Combination, 5 order -205.0
23.1
-239.1
-145.4
3
Combination, 6th order -203.0
22.8
-248.4
-147.3
rd
4
Combination, 3 order -201.6
20.6
-233.5
-150.9
th
5
Polynomial, 12 order
-200.1
27.5
-253.7
-130.3
6**
Polynomial, 20th order
-132.1
30.1
-181.7
-71.9
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.

Figure 3.15: The distributions of AICc values for all regions of the prostate and all saturation
amplitudes. The averages indicated on the boxplots are median values. * indicates the preferred
model.
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Table 3.12: AICc results of the models for all saturation amplitudes for the prostate cancer
patient images.
Rank Model
AICcmean
σAICc
AICcmin
AICcmax
th
1
Combination, 6 order -201.3
22.2
-248.4
-141.8
2
Combination, 5th order -200.2
22.7
-250.2
-138.2
th
3*
Combination, 4 order -196.2
24.9
-251.6
-123.1
th
4**
Polynomial, 12 order
-186.9
31.9
-263.4
-113.2
5**
Combination, 3rd order -186.0
21.6
-233.5
-124.2
th
6**
Polynomial, 20 order
-126.2
30.0
-186.9
-42.2
* indicates a significant difference (p < 0.05) between the marked model and the model with the
minimum AICc. ** indicates p < 0.001.
The preferred model selected by the AICc depended on the saturation amplitude. Table
3.13 lists the preferred fitting model for each of the saturation amplitudes tested. As seen with
the phantom images, the combination models were preferred to the high order polynomial
models for all saturation amplitudes tested, and increasing saturation amplitude decreased the
required order of the polynomial used for the portion of the Z-spectrum upfield from water
resonance.
Table 3.13: The preferred fitting models for the prostate cancer patient images as selected by
AICc for each of the saturation amplitudes tested.
Saturation Amplitude
Preferred Model
1.6 µT

6th Order Combination

2.4 µT

5th Order Combination

3.2 µT

4th Order Combination

4.0 µT

3rd Order Combination

All Amplitudes

6th Order Combination

3.3 RESULTS FOR AIM 3: BLADDER CANCER IMAGES
3.3.1 CURVE FITTING RESULTS
The bladder cancer patient images were acquired with a 4.0 µT saturation amplitude.
Data points were excluded when the signal intensity at a frequency offset fell below the
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threshold of 5% of S0, a procedure consistent with the exclusion procedure for the phantom data
sets. Because of this, the 4th order combination was selected as the model for fitting the Z-spectra
rather than the 3rd order combination model preferred for the prostate cancer patient images
acquired with a 4.0 µT saturation amplitude.
A representative example of Z-spectra and the resulting curve fits are plotted for both the
NBW and tumor regions in Figure 3.16. Generally, the points of the Z-spectra near water
resonance for tumor regions fell beneath the exclusion threshold. The NBW regions typically had
higher signal, and few data points were excluded from curve fitting. Seven patients had NBW Zspectra that appeared noisy compared to the Z-spectra for other patients. A representative
example of these Z-spectra and the resulting curve fits are plotted in Figure 3.17. This may be
due to patient motion during the acquisition.

Figure 3.16: A representative example of Z-spectral curve fits and MTRasym(ω) calculated from
the interpolated Z-spectra for (a) the NBW region and (b) the tumor region of the bladder cancer
patient images.
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Figure 3.17: An example of (a) a small ROI for the NBW region, and (b) the Z-spectrum in that
ROI for a patient who may have experienced bladder motion during acquisition.
3.3.2 BLADDER CANCER PATIENT MTR ASYMMETRY RESULTS
Using the Shapiro-Wilk test for normality on the distribution of MTRasym(2.0 ppm) and
MTRasym(3.5 ppm) values in both the NBW and tumor regions, the null hypothesis of normality
was unable to be rejected, enabling the use of the Student’s t-test.
A paired statistically significant difference was found between the MTRasym(3.5 ppm)
quantities in the NBW and tumor regions (p < 0.001), while no significant difference (p > 0.05)
was found between the MTRasym(2.0 ppm) quantities between the NBW and tumor regions.
The average MTRasym(3.5 ppm) value in NBW regions was -0.0119 ± 0.0478, while the
average value in tumor regions was 0.0336 ± 0.0225 (Figure 3.17a). The average MTRasym(2.0
ppm) value in NBW regions was -0.0020 ± 0.0569, while the average value in tumor regions was
0.0176 ± 0.0222 (Figure 3.17b).
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Figure 3.18: Boxplots of the distribution of (a) MTRasym(2.0 ppm) values and (b) MTRasym(3.5
ppm) values in both the NBW and tumor regions.
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CHAPTER 4: DISCUSSION AND CONCLUSIONS
4.1 RESULTS SUMMARY
In this work, a Z-spectral curve fitting model was proposed which separated the
components of the Z-spectrum upfield and downfield from water resonance during the fitting
process. Reported methods of Z-spectral analysis relied on high order polynomials for
interpolation, which were not based on the physics of CEST-MRI and were prone to exhibiting
oscillations near the edge of the fitting interval under some circumstances. The model proposed
in this work was partially based on the solution to the Bloch equations modified to account for
the transfer of magnetization between pools of protons either associated with solutes, immobile
macromolecules, or free water, and relies on lower order polynomials to fit half of the Zspectrum. This method of fitting both provided some physically meaningful fitting parameters
and reduced the magnitude of the oscillations. This method of fitting the upfield and downfield
sections separately was shown to be preferred based on the AICc model selection criterion. The
capability of MTRasym calculations made using this model to distinguish tumor from healthy
tissue was demonstrated for bladder cancer. The motivation for this work was the lack of a
standard procedure for data processing in CEST-MRI studies, combined with a lack of a standard
phantom for comparing results across MR systems.
It was hypothesized that a model which fit the regions of the Z-spectrum upfield and
downfield from water separately would result in fits of similar quality as the high order
polynomial functions reported in the literature while reducing the required number of fitting
parameters, and thus maintaining the ability to calculate useful MTRasym values. This was tested
by first applying the models to a comprehensive CEST-MRI phantom and calculating the AICc
for each to determine a preferred curve fitting model based on the minimum average AICc value.
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A subset of these models was then applied to a set of prostate cancer patient images and again
the preferred model was identified as the minimum average AICc. Finally, a model was selected
from the phantom and prostate cancer results and applied to bladder cancer images;
MTRasym(2.0 ppm) and MTRasym(3.5 ppm) values were calculated for both NBW and tumor
regions to determine if these regions could be distinguished by differences in MTR asymmetry
values.
For the phantom and prostate cancer patient images acquired at all saturation amplitudes,
a combination model was preferred using a 5th and 6th order polynomial, respectively, to describe
the downfield regions of the Z-spectra. A 4th order combination fitting method was applied to
bladder cancer patient images and the MTRasym(3.5 ppm) calculations were found to be
significantly different between NBW and tumor regions, demonstrating the ability of
MTRasym(3.5 ppm) calculations made using this model to distinguish NBW from tumor.
In addition to incorporating some physical meaning, this model has the potential to be
extended further to include terms describing Z-spectral contributions from NOE which would
make it suitable for application to CEST-MRI at ultra-high field strengths (greater than 3 T).
4.2 LIMITATIONS OF PROPOSED MODEL
The Lorentzian lineshape describing the effect of DWS in the combination upfield and
downfield fitting method was based on the solution to modified Bloch equations under the
assumption of weak saturation (Zhou, Wilson et al. 2004, Zaiß, Schmitt et al. 2011). In many
experimental conditions, this assumption will not be satisfied as the water signal will be fully
suppressed at saturation frequency offsets close to water resonance. This could result in large
variances in MTR asymmetry calculations made in regions where the assumption of weak
saturation fails.
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As with all methods for interpolating Z-spectra for MTR asymmetry calculations,
accurate B0 field inhomogeneity maps are required to ensure accurate calculations. Methods
which shift the Z-spectrum based on curve fitting results have the advantage of not requiring user
input when selecting appropriate sequence parameters for acquiring B0 field inhomogeneity
maps. Figure 3.1 demonstrates variation in B0 field inhomogeneity measurements made using the
same technique with differences in echo time separation. It has been shown that B0
inhomogeneities as small as 0.1 ppm can significantly affect the asymmetry calculations (Kim,
Gillen et al. 2009).
Separating the curve fitting process into two parts takes additional time to process. While
not problematic when fitting ROIs, the extra time may become an issue if the technique was
applied on a per-pixel basis. Processing multiple slices per image data set will add even more
time.
The present study only assesses the MTRasym values calculated using a single instance of
the combination model. This offers no basis for comparing the results of the high order
polynomial models reported in the literature to the results of the combination model.
4.3 AIM 1, DISCUSSION
Eight fitting models were applied to 84 data sets. Average AICc was calculated for each
model, with the models then ranked from the most negative average AICc to the largest average
AICc value. The 20th order polynomial model ranked last in 79 of the 84 data sets tested, and
ranked next to last for the remaining 5 data sets. Although the 20th order polynomial had the
lowest residual sum of squares for every data set, it consistently had the largest average AICc
because of the large ratio of fitting parameters to data points.
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At lower saturation amplitudes, the combination model with low order polynomials for
the downfield region of the Z-spectra generally performed poorly based on the AICc model
selection criteria, which was the result of the low order polynomial being unable to fit the
sharper curve in the Z-spectra. This contrasted with the 20th order polynomial which appeared to
fit the data well but was heavily penalized by the AICc for having many fitting parameters.
Increasing the saturation amplitude both increased the width of the DWS component of the Zspectra and increased the magnitude of the MT component (Zaiß, Schmitt et al. 2011), resulting
in the shoulders of the Z-spectra being less pronounced; this enabled the lower order polynomials
to perform better for the combination model. The 20th order polynomial fitting clearly exhibited
oscillations near the edges of the fitting intervals with the higher saturation amplitudes.
Near 0 ppm, where data points were excluded from the fitting process due to falling
beneath a threshold of signal of 5% of S0, the assumption of weak saturation failed. The
saturation amplitudes were chosen to reflect values that have been used in past experiments in
vivo (Jia, Abaza et al. 2011). In the future, imaging with a lower saturation amplitude may be
preferable to increase the number of data points for which the weak saturation approximation is
applicable. The performance of the 20th order polynomial model suffered due to this exclusion of
data points during the curve fitting process, effectively increasing the ratio of the number of
fitting parameters to the number of data points.
4.4 AIM 2, DISCUSSION
Six fitting models were applied to 232 Z-spectral data sets acquired from the prostate
cancer patient images. Similar to the phantom results, the 20th order polynomial model had the
greatest average AICc values over all data sets despite having the least residual sum of squares
values for all data sets.
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As with the phantom results, the combination models were the preferred curve fitting
models. The order of the polynomial used to fit the downfield region of the Z-spectra decreased
with increasing saturation amplitude. This was due to the increase in the MT effect as well as the
broadening of the DWS component of the Z-spectra, as referenced in the previous section. At
lower saturation amplitudes, the 3rd and 4th order polynomials used for the combination model
did not adequately fit the Z-spectra. At higher saturation amplitudes, the combination models
using 3rd and 4th order polynomials were preferred based on having smaller average AICc values.
For the Z-spectral data from prostate cancer patient images, data points near the center of
the Z-spectra were not excluded because of previous experience with these data sets indicating
that this would not be necessary to achieve good fitting (Schurr, Elias et al. 2014). This previous
study applied Equation 2.1 to the full set of Z-spectral data. Although regions in the center of the
Z-spectrum were close to the exclusion threshold applied to the phantom Z-spectra, the quality of
the fitting was still good based on the average AICc values used for the preferred model
selection.
4.5 AIM 3, DISCUSSION
The 4th order combination model was applied to the bladder cancer patients because this
had the most negative average AICc values for the phantom at a saturation amplitude of 4.0 µT,
which was the saturation amplitude used during the acquisition of the bladder cancer patient
images. The curve fitting procedure in the bladder followed the same exclusion process as in the
phantom. For this reason, the preferred 4th order combination model from the phantom study was
selected over the preferred 3rd order combination model from the prostate cancer patient study.
The MTRasym(3.5 ppm) values were statistically significantly greater in the tumor regions
than the NBW regions, which showed that this quantity has the potential to distinguish these
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regions. The MTRasym(2.0 ppm) values were not statistically significantly different between the
two regions, but this potentially was due to the large saturation amplitude used in the experiment.
The signal intensity at a frequency offset of ±2.0 ppm was very close to the exclusion threshold
for many of the Z-spectra. Repeating the experiment with a reduced saturation amplitude may
yield different results.
The Z-spectra collected in the NBW regions for some patients did not have the smooth Zspectral shape as shown for the phantom or prostate cancer patient images. This was likely due to
bladder motion during the imaging procedure. For frequency offsets far from water resonance,
the ROI can be adjusted to account for motion; however, at frequency offsets close to water
resonance there is low signal and it is not always possible to account for motion. The ROIs for
the NBW regions were very small, and the boundaries of the bladder wall were not always clear
in the CEST-MR images. Though to date there have been no studies on CEST-MRI of bladder
cancer published and indexed in the PubMed database, the quantity MTRasym(3.5 ppm) has been
shown in studies of other sites to have the ability to distinguish disease from healthy tissue (Jia,
Abaza et al. 2011).
4.6 DIRECTION OF FUTURE WORK
Future work on this fitting model may need to constrain the slopes of the fits in the
upfield and downfield regions to match at the origin to prevent artifacts in MTR asymmetry
calculations at saturation frequency offsets close to water resonance. This will become more
important at lower saturation amplitudes, or for imaging solutes which exhibit a CEST effect
near water resonance such as glycogen. Eventually, the combination model for curve fitting
could be written into a standalone image processing software and made available for use by the
community.
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Establishing MTRasym calculations as a clinically relevant quantitative imaging biomarker
will require additional work to establish the scan-rescan and cross-system reproducibility. A
standard CEST-MRI phantom will be useful for this process, and the phantom used in this study
could be modified for this role. The size of the phantom should be reduced to enable it to fit in
smaller detector coils. Changing the temperature or pH of the phantoms may be useful as well.
If new terms were added to the fitting model to account for NOE, the model could be
applied to CEST-MRI at ultra-high field strengths. Many CEST-MRI studies are performed at
field strengths greater than 3 T, and adapting the model to apply to these conditions would
increase the number of studies for which the model would be relevant.
The bladder cancer study could be extended to include patient images from follow-up
MR scans. For patients undergoing chemotherapy for instance, one could assess changes in
MTRasym in response to therapy. Another venue is to assess whether MTRasym can predict a
patient’s response to chemotherapy.
In conclusion, the Z-spectral analysis method proposed in this study of fitting the upfield
and downfield regions of the Z-spectrum separately provided a better model than some higher
order polynomial models reported in the literature, according to the AICc model selection
criteria. This was demonstrated in both phantom and patient images using multiple amplitudes
for the saturation pre-pulse. Additionally, the model provided a model based in part on the
physics of MT-MRI and CEST-MRI. The application of the model to bladder cancer patients
demonstrated that the MTRasym(3.5 ppm) calculations performed using the combination can
provide quantitative methods of distinguishing NBW from bladder cancer, a site which has not
been previously studied by with CEST-MRI.
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